Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Up Front MattersEditorials
You have accessRestricted Access

The Science of Fistula Maturation

Matthew J. Oliver
JASN November 2018, 29 (11) 2607-2609; DOI: https://doi.org/10.1681/ASN.2018090922
Matthew J. Oliver
Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • View PDF
Loading
  • access blood flow
  • arteriovenous fistula
  • ESRD

International guidelines strongly recommend that patients with ESRD undergoing maintenance hemodialysis receive an arteriovenous fistula because its use is associated with lower mortality and allows patients to avoid the risk of catheter-related complications.1–3 Fistula use is a frequent target for performance measurement and quality improvement, and it is tied to reimbursement in the United States. These guidelines and policies create strong incentives for providers to aggressively promote fistulas to their patients.

However, the purported benefits of fistulas are not realized unless the vascular access matures. Clinical maturation is a dynamic process in which vascular remodeling is facilitated by release of nitrous oxide and breakdown of elastin to permit enlargement of the draining vein.4 Blood flow through the anastomosing artery increases dramatically and the vein wall thickens to allow regular cannulation. For example, mean blood flow in the radial artery, only 64 ml/min before fistula creation, can increase ten-fold to achieve maturation5; mean blood flow in the brachial artery, about 220 ml/min at baseline, often increases to over 1000 ml/min in a mature upper arm fistula. A useful rule of thumb to define clinical maturation proposed by the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for vascular access is the “rule of sixes,” which says that a mature fistula should achieve a blood flow of at least 600 ml/min, a diameter of at least 6 mm, and a depth of 6 mm or less from the surface of the skin.1

Studies of fistula outcomes vary in their definitions of the lack of clinical maturation (otherwise known as primary failure), but it is usually defined as some combination of early thrombosis, poor blood flow, inadequate clearance, or unreliable use. A meta-analysis of observational studies by our group estimated the risk of primary failure to be 23%, on the basis of 37 studies.6 However, two large, randomized clinical trials testing the effect of fish oil or clopidogrel on primary failure found the risk to be much higher, 47% and 62%, respectively.7,8 These studies found that neither intervention helped reduce primary failure. Regardless of which estimate is used, the risk of primary failure is likely high in many programs, a frustrating circumstance for both patients and clinicians. It is of paramount importance to better understand clinical maturation and to detect fistulas at risk for failure early to allow for timely intervention.

The Hemodialysis Fistula Maturation study is a large multicenter study that attempted to identify predictors and underlying mechanisms of fistula maturation.9 The authors measured numerous factors related to vascular anatomy, vascular biology, clinical attributes (demographics, comorbidities, and medications), and processes of care in patients undergoing fistula creation. In this issue of the Journal of the American Society of Nephrology, Robbin et al.10 describe how postoperative ultrasound measures can predict clinical maturation, defined as fistula use for 75% of treatments over a 4-week period with adequate blood flow and clearance. Clinical maturation occurred in 75% of patients, although 25% required interventions to mature the fistula. Ultrasound imaging took place 1 day and 2 and 6 weeks after fistula creation.

As suggested by the rule of sixes, fistula blood flow, diameter, and depth were significant predictors of maturation. However, the authors describe these relationships in much more detail compared with previous studies. Their primary analysis compared the 15th and 85th percentiles for these three continuous parameters. Compared with the 15th percentile, the increases in fistula blood flow and diameter in the 85th percentile were associated with a four-fold or greater increases in odds of unassisted clinical maturation. The likelihood of clinical maturation also doubled as depth decreased from the 15th percentile to the 85th percentile. The authors also present a number of forest plots, contour plots, and figures showing the likelihood of clinical maturation with different combinations of flow, diameter, and depth. In general, the relationship between flow and maturation was steep between blood flows of 500 ml/min to 1200 ml/min, but it was modified by the depth and diameter. The overall predictive value of these measures was considered moderate. The description of these relationships is novel and greatly increases the precision of predicting maturation.

Measuring flow, diameter, and depth in the postoperative period as part of routine care now seems reasonable to guide clinicians in decision making. Many programs already perform Doppler ultrasound to measure blood flow on newly created fistulas, so adding assessments of diameter and depth would be relatively easy for those not already measuring these parameters. If these three measures become available in most centers, further studies could validate the generalizability of the current findings. It would also be helpful to have a method (e.g., a calculator) to easily generate the predicted chance of maturation at specific time points of postoperative follow-up. Studies could then determine how this new information might improve decision making. On the basis of the predicted likelihood of unassisted maturation, timely intervention to facilitate maturation (e.g., using angioplasty or collateral vein occlusion) or early planning of a second fistula could increase fistula use and reduce exposure to central venous catheters.

A final caveat to this study was the center effect, specifically the differences in maturation probabilities among the participating clinical centers. Despite adjusting for case-mix and the three independent predictors of maturation (flow, diameter, and depth), the center effect was still significant. Unassisted patency across centers ranged from 26% to 68% and assisted patency ranged from 61% to 88%. It is unclear if this center effect is related to surgical experience, volume, or interest in fistulas. Program practices in the preoperative and postoperative periods may also be important. For example, an earlier study this year by Allon et al.11 from the Hemodialysis Fistula Maturation study found that timing and number of postoperative visits by surgeons, along with presence of vascular access coordinators, influence outcomes. Further studies are required to understand what practices or interventions are driving these differences among centers. In the meantime, careful postoperative measures of flow, diameter, and depth can bring more science to the process of clinical maturation.

Disclosures

M.J.O. declares research support from Baxter Healthcare, is a consultant to Pursuit Vascular, Inc., and is the inventor of Dialysis Measurement Analysis and Reporting systems.

Footnotes

  • Published online ahead of print. Publication date available at www.jasn.org.

  • See related article, “Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation Study,” on pages 2735–2744.

  • Copyright © 2018 by the American Society of Nephrology

References

  1. ↵
    National Kidney Foundation: KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: Hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 48[Suppl 1]: 1–322, 2006
    OpenUrlCrossRefPubMed
    1. Tordoir J,
    2. Canaud B,
    3. Haage P,
    4. Konner K,
    5. Basci A,
    6. Fouque D, et al
    .: EBPG on vascular access. Nephrol Dial Transplant 22[Suppl 2]: ii88–ii117, 2007
    OpenUrlCrossRefPubMed
  2. ↵
    1. Jindal K,
    2. Chan CT,
    3. Deziel C,
    4. Hirsch D,
    5. Soroka SD,
    6. Tonelli M, et al
    .: Canadian Society of Nephrology Committee for Clinical Practice Guidelines: Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 17[Suppl 1]: S1–S27, 2006
    OpenUrlFREE Full Text
  3. ↵
    1. Riella MC,
    2. Roy-Chaudhury P
    : Vascular access in haemodialysis: Strengthening the Achilles’ heel. Nat Rev Nephrol 9: 348–357, 2013
    OpenUrlCrossRefPubMed
  4. ↵
    1. Masengu A,
    2. McDaid J,
    3. Maxwell AP,
    4. Hanko JB
    : Preoperative radial artery volume flow is predictive of arteriovenous fistula outcomes. J Vasc Surg 63: 429–435, 2016
    OpenUrl
  5. ↵
    1. Al-Jaishi AA,
    2. Oliver MJ,
    3. Thomas SM,
    4. Lok CE,
    5. Zhang JC,
    6. Garg AX, et al
    .: Patency rates of the arteriovenous fistula for hemodialysis: A systematic review and meta-analysis. Am J Kidney Dis 63: 464–478, 2014
    OpenUrlCrossRefPubMed
  6. ↵
    1. Dember LM,
    2. Beck GJ,
    3. Allon M,
    4. Delmez JA,
    5. Dixon BS,
    6. Greenberg A, et al
    .: Dialysis Access Consortium Study Group: Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: A randomized controlled trial. JAMA 299: 2164–2171, 2008
    OpenUrlCrossRefPubMed
  7. ↵
    1. Irish AB,
    2. Viecelli AK,
    3. Hawley CM,
    4. Hooi LS,
    5. Pascoe EM,
    6. Paul-Brent PA, et al
    .: Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group: Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: A randomized clinical trial. JAMA Intern Med 177: 184–193, 2017
    OpenUrl
  8. ↵
    1. Dember LM,
    2. Imrey PB,
    3. Beck GJ,
    4. Cheung AK,
    5. Himmelfarb J,
    6. Huber TS, et al
    .: Hemodialysis Fistula Maturation Study Group: Objectives and design of the hemodialysis fistula maturation study. Am J Kidney Dis 63: 104–112, 2014
    OpenUrlCrossRefPubMed
  9. ↵
    1. Robbin ML,
    2. Greene T,
    3. Allon M,
    4. Dember LM,
    5. Imrey PB,
    6. Cheung AK, et al
    .: Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation Study. J Am Soc Nephrol 29: 2735–2744, 2018
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Allon M,
    2. Imrey PB,
    3. Cheung AK,
    4. Radeva M,
    5. Alpers CE,
    6. Beck GJ, et al
    .: Hemodialysis Fistula Maturation (HFM) Study Group: Relationships between clinical processes and arteriovenous fistula cannulation and maturation: A multicenter prospective cohort study. Am J Kidney Dis 71: 677–689, 2018
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 29 (11)
Journal of the American Society of Nephrology
Vol. 29, Issue 11
November 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
The Science of Fistula Maturation
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Science of Fistula Maturation
Matthew J. Oliver
JASN Nov 2018, 29 (11) 2607-2609; DOI: 10.1681/ASN.2018090922

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
The Science of Fistula Maturation
Matthew J. Oliver
JASN Nov 2018, 29 (11) 2607-2609; DOI: 10.1681/ASN.2018090922
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Footnotes
    • References
  • Info & Metrics
  • View PDF

More in this TOC Section

Up Front Matters

  • Me Or Your Own Eyes: RNA-Seq and the Kidney
  • Automated Quantification of Chronic Changes in the Kidney Biopsy: Another Step in the Right Direction
  • Passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act—a Chance to Celebrate and Reflect
Show more Up Front Matters

Editorials

  • Race and the Estimation of GFR: Getting it Right
  • Monkeying about with Nephron Formation
  • Kidney Transplant Rejection Clusters and Graft Outcomes: Revisiting Banff in the Era of “Big Data”
Show more Editorials

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation Study
  • PubMed
  • Google Scholar

Keywords

  • access blood flow
  • arteriovenous fistula
  • ESRD

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire